ArticleScientific reports2024
A large scale multi institutional study for radiomics driven machine learning for meningioma grading.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Established machine learning matches tabular foundation models in clinical predictions.BMC medical informatics and decision making · 2026Article
- Multidisciplinary management of meningiomas in the era of precision oncology.Nature reviews. Clinical oncology · 2026Review
- MRI and Meningioma Research: Hotspots and Trends via Bibliometric AnalysisCurrent medical imaging · 2026Article
- Optimizing meningioma grading with radiomics and deep features integration, attention mechanisms, and reproducibility analysis.European journal of medical research · 2025Article
- Advancements in the application of MRI radiomics in meningioma.Radiation oncology (London, England) · 2025Review
- Addressing the current challenges in the clinical application of AI-based Radiomics for cancer imaging.Frontiers in medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aims to develop and evaluate radiomics-based machine learning (ML) models for predicting meningioma grades using multiparametric magnetic resonance imaging (MRI). The study utilized the BraTS-MEN dataset's training split, including 698 patients (524 with grade 1 and 174 with grade 2-3 meningiomas). We extracted 4872 radiomic features from T1, T1 with contrast, T2, and FLAIR MRI sequences using PyRadiomics. LASSO regression reduced features to 176. The data was split into training (60%), validation (20%), and test (20%) sets. Five ML algorithms (TabPFN, XGBoost, LightGBM, CatBoost, and Random Forest) were employed to build models differentiating low-grade (grade 1) from high-grade (grade 2-3) meningiomas. Hyperparameter tuning was performed using Optuna, optimizing model-specific parameters and feature selection. The CatBoost model demonstrated the best performance, achieving an area under the receiver operating characteristic curve (AUROC) of 0.838 [95% confidence interval (CI): 0.689-0.935], precision of 0.492 (95% CI: 0.371-0.623), recall of 0.838 (95% CI: 0.689-0.935), F1 score of 0.620 (95% CI: 0.495-0.722), accuracy of 0.729 (95% CI: 0.650-0.800), an area under the precision-recall curve (AUPRC) of 0.620 (95% CI: 0.433-0.753), and Brier score of 0.156 (95% CI: 0.122-0.200). Other models showed comparable performance, with mean AUROCs ranging from 0.752 to 0.784. The radiomics-based ML approach presented in this study showcases the potential for non-invasive and pre-operative grading of meningiomas using multiparametric MRI. Further validation on larger and independent datasets is necessary to establish the robustness and generalizability of these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.